AGP Executive Report
Last update: 9 hours agoClinical Trial Watch: Finnish biotech Aplagon raised €4.8m to expand its antithrombotic programme into a new Phase II trial, targeting vascular access failure in haemodialysis (AVF maturation) and aiming for sustained anti-clot and anti-inflammatory effects at injury sites. Public Health & Care Access: Finland is also pushing a Talent Boost Programme to fill shortages in healthcare and digital roles, including fast-tracking residence permits for skilled workers and families—an approach that could ease pressure on services as the workforce shrinks. Mental Health & Loneliness: New research highlights how loneliness can ease with support tech, with a study finding a small but noticeable reduction in loneliness over three months when older adults used voice assistants, especially with video calling. Cancer Awareness: Tragic reports from the UK describe a young woman who initially thought she had a chest infection but was later diagnosed with lymphoma—an urgent reminder to take persistent symptoms seriously. Emergency Medicine Capacity: Avincis signed for up to 15 more Airbus H145 helicopters to strengthen Helicopter Emergency Medical Services across Europe, including the Nordics.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.